Patients should be advised to seek urgent medical attention if they experience any of the following symptoms: Sudden onset of floaters or 'cobwebs' in the vision , which may indicate vitreous haemorrhage Flashing lights or photopsia , suggesting retinal traction or impending detachment A curtain or shadow across the visual field , which may represent retinal detachment Sudden blurring or loss of central vision , potentially indicating macular oedema or ischaemia Distortion of straight lines (metamorphopsia), which can be an early sign of macular pathology In the context of initiating or up-titrating Mounjaro, ophthalmology referral timing should follow NHS Diabetic Eye Screening Programme and local pathways: Proliferative diabetic retinopathy (PDR) requires urgent referral, often within 1-2 weeks, or same-day assessment if acute symptoms are present [17] Suspected centre-involving diabetic macular oedema with visual symptoms warrants urgent assessment Moderate to severe non-proliferative diabetic retinopathy identified on screening should be referred according to local DESP pathways Any worsening of retinopathy during Mounjaro treatment should prompt ophthalmology review For patients without known retinopathy but with multiple risk factors (long diabetes duration, poor baseline control, hypertension), ensure up-to-date DESP screening and consider a pre-treatment ophthalmology assessment to establish a baseline
Depending on your health history and unique goals, a clinician can determine which prescription medication is right for you
Brunilda Nazario, chief medical officer of medical affairs at WebMD told Flow Space
The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels
81970290), the Joint Funds of the National Natural Science Foundation of China (No
